122 related articles for article (PubMed ID: 2047543)
21. Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat.
Ohta H; Kato Y; Shimatsu A; Tojo K; Kabayama Y; Inoue T; Yanaihara N; Imura H
Eur J Pharmacol; 1985 Mar; 109(3):409-12. PubMed ID: 3872804
[TBL] [Abstract][Full Text] [Related]
22. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
[TBL] [Abstract][Full Text] [Related]
23. Galanin stimulates the release of vasoactive intestinal polypeptide from perifused hypothalamic fragments in vitro and from periventricular structures into the cerebrospinal fluid in vivo in the rat.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Feb; 85(1):95-100. PubMed ID: 2452388
[TBL] [Abstract][Full Text] [Related]
24. Effect of vasoactive intestinal peptide on the release of growth hormone in perifused pituitary and hypothalamus of the goat.
Ogwuegbu SO; Hashizume T; Kanematsu S
Domest Anim Endocrinol; 1991 Jan; 8(1):29-35. PubMed ID: 2013223
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide (VIP) mediates the effect of estrogens on the dopaminergic tone in the hypothalamic-pituitary axis of ovariectomized (OVX) rats.
Lasaga M; Seilicovich A; Pisera D; Díaz MC; Befumo MF; Duvilanski BH
Endocrine; 1997 Feb; 6(1):53-6. PubMed ID: 9225116
[TBL] [Abstract][Full Text] [Related]
26. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
Murai I; Reichlin S; Ben-Jonathan N
Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide levels in the hypothalamus and anterior pituitary do not change in association with the pre-ovulatory prolactin surge in the rat.
Watanobe H; Sasaki S; Takebe K
Neuropeptides; 1991 Nov; 20(3):159-62. PubMed ID: 1762665
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.
Hyde JF; Morrison DG; Drake KW; Moore JP; Maley BE
J Neuroendocrinol; 1996 Jan; 8(1):9-15. PubMed ID: 8932732
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide is a hypothalamic prolactin-releasing neuropeptide in the turkey (Meleagris gallopavo).
el Halawani ME; Silsby JL; Mauro LJ
Gen Comp Endocrinol; 1990 Apr; 78(1):66-73. PubMed ID: 2158920
[TBL] [Abstract][Full Text] [Related]
30. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
31. [Characterization of the stimulant effect of 2 neuropeptides (thyroliberin (TRH) and vasoactive intestinal peptide (VIP)) on the secretion of the growth hormone in the rat].
Durand D; Bluet-Pajot MT; Mounier F; Leonard JF; Pressac M
Reprod Nutr Dev (1980); 1987; 27(2B):481-9. PubMed ID: 3114836
[TBL] [Abstract][Full Text] [Related]
32. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment.
Poplawski MM; Boyadjieva N; Sarkar DK
Alcohol Clin Exp Res; 2005 Apr; 29(4):648-55. PubMed ID: 15834231
[TBL] [Abstract][Full Text] [Related]
33. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal polypeptide and dopamine in the hypothalamus and pituitary of ageing rats with prolactinomas.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Merry BJ
Acta Endocrinol (Copenh); 1987 Sep; 116(1):150-4. PubMed ID: 3661055
[TBL] [Abstract][Full Text] [Related]
35. Effects of hachimijiogan on dopamine, serotonin and vasoactive intestinal peptide in plasma and hypothalamus in sulpiride-induced hyperprolactinemic rats.
Usuki S; Ichikawa Y
Am J Chin Med; 1991; 19(3-4):217-22. PubMed ID: 1767793
[TBL] [Abstract][Full Text] [Related]
36. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
[TBL] [Abstract][Full Text] [Related]
38. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
Lam KS; Srivastava G; Tam SP
Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
[TBL] [Abstract][Full Text] [Related]
39. Evidence that vasoactive intestinal polypeptide is a physiological prolactin-releasing factor in the bantam hen.
Macnamee MC; Sharp PJ; Lea RW; Sterling RJ; Harvey S
Gen Comp Endocrinol; 1986 Jun; 62(3):470-8. PubMed ID: 3770438
[TBL] [Abstract][Full Text] [Related]
40. Prolactin and LH release in response to vasoactive intestinal peptide (VIP) administration in spontaneously hypertensive and normotensive rats.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Staff-Zielińska E; Kochman K
Endokrynol Pol; 1992; 43(2):137-44. PubMed ID: 1345535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
